APPLICATION
ANDA090449
TYPE
ANDA
ORIGINAL APPROVAL
2015-07-20
LATEST ACTION
2024-02-13
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
BIMATOPROSTPrescription
BIMATOPROST 0.03% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2024-02-13Labeling · Supplement 7 · standardAP
2022-12-01Labeling · Supplement 8 · standardAP
2018-11-20Manufacturing (CMC) · Supplement 3 · unknownAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.